Stay updated with breaking news from Lobe Sciences Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires
Psychedelics biopharma company Lobe Sciences Ltd. (OTCQB:LOBEF) signed a deal with Cantheon Capital, a development of cannabinoids and psyche...
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires
“The opportunity to advance our proprietary psilocin compounds in multiple human trials puts Lobe in a leading position within the...
Vancouver, British Columbia--(Newsfile Corp. - September 1, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a Canadian Biopharmaceutical company committed to discovering